Interestingly, we now have data showing that the Notch signaling pathway, Notch3 in particular, plays a key role in cancer stem cell (CSC) maintenance and paclitaxel(PTX)-resistance [4, 5]. This evidence concerns the gene NOTCH3 and cancer.